High time for high-flux hemodialysis mechanistic studies

Blood Purification

Volumn 26, Issue 2, 2008, Pages 211-212

  Axelsson, Jonas ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; CYTOKINE;

ACUTE KIDNEY FAILURE; ARTIFICIAL KIDNEY; EDITORIAL; HEMODIALYSIS; HUMAN; INSULIN METABOLISM; INSULIN RESISTANCE; KIDNEY METABOLISM; MORTALITY; OXIDATIVE STRESS; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; UREMIA;

HUMANS; MEMBRANES, ARTIFICIAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 40949126173     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000117439     Document Type: Editorial

References (9)

1. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, et al: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002;347:2010-2019.
2. Delmez JA, Yan G, Bailey J, Beck GJ, et al: Cerebrovascular disease in maintenance hemodialysis patients: results of the HEMO Study. Am J Kidney Dis 2006;47:131-138.
3. Port FK, Wolfe RA, Hulbert-Shearon TE, Daugirdas JT, et al: Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: results from the USRDS Dialysis Morbidity and Mortality Study. Am J Kidney Dis 2001;37:276-286.
4. Krane V, Krieter DH, Olschewski M, Marz W, et al: Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysis. Am J Kidney Dis 2007;49:267-275.
5. Leypoldt JK, Cheung AK, Carroll CE, Stannard DC, et al: Effect of dialysis membranes and middle molecule removal on chronic hemodialysis patient survival. Am J Kidney Dis 1999;33:349-355.
6. 2-microglobulin levels predict mortality in dialysis patients: results of the HEMO Study. J Am Soc Nephrol 2006;17: 546-555.
7. Axelsson J, Bergsten A, Qureshi AR, Heimburger O, et al: Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. Kidney Int 2006;69:596-604.
8. Kalantar-Zadeh K: Inflammatory marker mania in chronic kidney disease: pentraxins at the crossroad of universal soldiers of inflammation. Clin J Am Soc Nephrol 2007;2: 872-875.
9. Haase M, Bellomo R, Baldwin I, Haase-Fielitz A, et al: Hemodialysis membrane with a high-molecular-weight cutoff and cytokine levels in sepsis complicated by acute renal failure: a phase 1 randomized trial. Am J Kidney Dis 2007;50:296-304.